Literature DB >> 4542779

Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.

T R Griggs, H A Cooper, W P Webster, R H Wagner, K M Brinkhous.   

Abstract

The human-platelet aggregating factor in preparations of bovine plasma and bovine antihemophilic factor has been reported to be an activity of bovine antihemophilic factor. However, we show that activities of aggregating factor and antihemophilic factor are present in varying proportion in different preparations of antihemophilic factor. Aggregating factor activity is more stable on storage than is antihemophilic factor activity and can be selectively adsorbed by human platelets. Further, antihemophilic factor activity free of aggregating activity was eluted from DEAE-Sephadex. The factors were also separated during agarose chromatography in 0.25 M CaCl(2), which yields a small-molecular-weight moiety with antihemophilic factor activity; aggregating factor activity continued to elute in the void volume. Thus, aggregating factor activity is clearly separable from antihemophilic factor activity. The usual physiologic platelet-aggregating reactions require fresh platelets. Fresh, aged, and sonicated platelets, but not platelets that have been frozen and thawed, react with aggregating factor, indicating that the platelet "receptor sites" for the aggregating factor are unusually stable.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4542779      PMCID: PMC427115          DOI: 10.1073/pnas.70.10.2814

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.

Authors:  B N Bouma; Y Wiegerinck; J J Sixma; J A Van Mourik; I A Mochtar
Journal:  Nat New Biol       Date:  1972-03-29

2.  Aggregation of human platelets by purified porcine and bovine antihaemophilic factor.

Authors:  C D Forbes; C R Prentice
Journal:  Nat New Biol       Date:  1973-01-31

3.  Gel filtration. A new technique for separation of blood platelets from plasma.

Authors:  O Tangen; H J Berman; P Marfey
Journal:  Thromb Diath Haemorrh       Date:  1971-06-30

4.  The isolation nd characterization of bovine factor VIII (antihemophilic factor).

Authors:  G Schmer; E P Kirby; D C Teller; E W Davie
Journal:  J Biol Chem       Date:  1972-04-25       Impact factor: 5.157

5.  Platelet response to six agglutinating agents: species similarities and differences.

Authors:  R G Mason; M S Read
Journal:  Exp Mol Pathol       Date:  1967-06       Impact factor: 3.362

6.  Aggregation of human platelets by bovine platelet fibrinogen.

Authors:  N O Solum
Journal:  Scand J Haematol       Date:  1968

7.  Possible implications of the autosomal and X-linked hemophilia phenotypes.

Authors:  J B Graham; E M Barrow; H R Roberts
Journal:  Thromb Diath Haemorrh Suppl       Date:  1965

8.  A clinical and experimental study of acquired inhibitors to factor 8.

Authors:  H R Roberts; M B Scales; J T Madison; W P Webster; G D Penick
Journal:  Blood       Date:  1965-12       Impact factor: 22.113

9.  Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin.

Authors:  C D Forbes; R D Barr; G P McNicol; A S Douglas
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

10.  Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography.

Authors:  H J Weiss; L L Phillips; W Rosner
Journal:  Thromb Diath Haemorrh       Date:  1972-04-30
View more
  14 in total

1.  Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.

Authors:  M E Switzer; P A McKee
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  Defective ristocetin and bovine factor VIII-induced platelet aggregation in normal rats.

Authors:  G de Gaetano; M B Donati; I Reyers-Degli Innocenti; M C Roncaglioni
Journal:  Experientia       Date:  1975-04-15

3.  Nature of von Willebrand factor: a new assay and a specific inhibitor.

Authors:  K E Sarji; R D Stratton; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

Review 4.  Platelets, thrombosis and drugs.

Authors:  J F Mustard; M A Packham
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.

Authors:  T R Griggs; J S Potter; S B McClanahan; W P Webster; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.

Authors:  H A Cooper; K J Clemetson; E F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

Authors:  T C Nichols; C M Samama; D A Bellinger; J Roussi; R L Reddick; M Bonneau; M S Read; O Bailliart; G G Koch; M Vaiman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Antibody nature of circulating inhibitor of plasma von Willebrand factor.

Authors:  R D Stratton; R H Wagner; W P Webster; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

9.  The interaction of bovine factor VIII with human platelets.

Authors:  E P Kirby; D C Mills
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

10.  Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.

Authors:  M E Switzer; P A McKee
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.